{"id":"https://openalex.org/W7212937272","doi":"https://doi.org/10.1007/s40801-026-00579-1","title":"Use of Sotatercept in France since Its Availability in June 2024: A Nationwide Study from the French Health Data System (SNDS)","display_name":"Use of Sotatercept in France since Its Availability in June 2024: A Nationwide Study from the French Health Data System (SNDS)","publication_year":2026,"publication_date":"2026-09-14","ids":{"openalex":"https://openalex.org/W7212937272","doi":"https://doi.org/10.1007/s40801-026-00579-1","pmid":"https://pubmed.ncbi.nlm.nih.gov/42734777"},"language":"en","primary_location":{"id":"doi:10.1007/s40801-026-00579-1","doi":"https://doi.org/10.1007/s40801-026-00579-1","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40801-026-00579-1","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40801-026-00579-1.pdf","source":{"id":"https://openalex.org/S2764379982","display_name":"Drugs - Real World Outcomes","issn_l":"2198-9788","issn":["2198-9788","2199-1154"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs - Real World Outcomes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s40801-026-00579-1.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5092165742","display_name":"Charifa Nazoiri","orcid":"https://orcid.org/0000-0003-0474-6443","observed_orcids":["https://orcid.org/0000-0003-0474-6443"]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Nazoiri Charifa","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France. Charifa.nazoiri@ansm.sante.fr"],"raw_orcid":"https://orcid.org/0000-0003-0474-6443","affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France. Charifa.nazoiri@ansm.sante.fr","institution_ids":["https://openalex.org/I4210120216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080099253","display_name":"Alain Weill","orcid":"https://orcid.org/0000-0001-8687-9092","observed_orcids":["https://orcid.org/0000-0001-8687-9092"]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alain Weill","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France","institution_ids":["https://openalex.org/I4210120216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059005646","display_name":"Mahmoud Zureik","orcid":"https://orcid.org/0000-0002-8393-4217","observed_orcids":["https://orcid.org/0000-0002-8393-4217"]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mahmoud Zureik","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France","institution_ids":["https://openalex.org/I4210120216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079651779","display_name":"J\u00e9r\u00e9mie Botton","orcid":"https://orcid.org/0000-0002-4814-6370","observed_orcids":["https://orcid.org/0000-0002-4814-6370"]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J\u00e9r\u00e9mie Botton","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France","institution_ids":["https://openalex.org/I4210120216"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035651354","display_name":"Nadia Haddy","orcid":"https://orcid.org/0000-0001-9316-8280","observed_orcids":["https://orcid.org/0000-0001-9316-8280"]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nadia Haddy","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France","institution_ids":["https://openalex.org/I4210120216"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5092165742"],"corresponding_institution_ids":["https://openalex.org/I4210120216"],"apc_list":{"value":3090,"currency":"USD","value_usd":3090},"apc_paid":{"value":3090,"currency":"USD","value_usd":3090},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12199","display_name":"Vascular Anomalies and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sotatercept","display_name":"sotatercept","score":1.0},{"id":"https://openalex.org/keywords/pulmonary-arterial-hypertension","display_name":"pulmonary arterial hypertension","score":1.0},{"id":"https://openalex.org/keywords/early-access-program","display_name":"early access program","score":0.8690000176429749},{"id":"https://openalex.org/keywords/real-world-applications","display_name":"real-world applications","score":0.7120000123977661},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.6970000267028809},{"id":"https://openalex.org/keywords/dosing-interval","display_name":"dosing interval","score":0.656000018119812},{"id":"https://openalex.org/keywords/background-therapy","display_name":"background therapy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.36800000071525574},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.32899999618530273},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.49300000071525574},{"id":"https://openalex.org/keywords/lung-transplantation","display_name":"lung transplantation","score":0.8309999704360962},{"id":"https://openalex.org/keywords/france","display_name":"France","score":0.4230000078678131}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8977000117301941},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.49140000343322754},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.427700012922287},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4140999913215637},{"id":"https://openalex.org/C2983914783","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Lung disease","level":3,"score":0.40720000863075256},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4066999852657318},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4052000045776367},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.38679999113082886},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3626999855041504},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.3549000024795532},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.33329999446868896},{"id":"https://openalex.org/C13543017","wikidata":"https://www.wikidata.org/wiki/Q4430231","display_name":"Social deprivation","level":2,"score":0.3197000026702881},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.31869998574256897},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3181000053882599},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.31119999289512634},{"id":"https://openalex.org/C2775832928","wikidata":"https://www.wikidata.org/wiki/Q407954","display_name":"Expanded access","level":2,"score":0.30000001192092896},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.2879999876022339},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2840999960899353},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.2825999855995178},{"id":"https://openalex.org/C2988170871","wikidata":"https://www.wikidata.org/wiki/Q11000047","display_name":"Healthcare system","level":3,"score":0.27649998664855957},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.2750000059604645},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.27399998903274536},{"id":"https://openalex.org/C2776178081","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory disease","level":3,"score":0.260699987411499},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.25940001010894775},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.2581000030040741},{"id":"https://openalex.org/C3017977704","wikidata":"https://www.wikidata.org/wiki/Q18745135","display_name":"Health data","level":3,"score":0.25699999928474426},{"id":"https://openalex.org/C2780877353","wikidata":"https://www.wikidata.org/wiki/Q2518253","display_name":"Health services research","level":3,"score":0.25369998812675476}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1007/s40801-026-00579-1","doi":"https://doi.org/10.1007/s40801-026-00579-1","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40801-026-00579-1","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40801-026-00579-1.pdf","source":{"id":"https://openalex.org/S2764379982","display_name":"Drugs - Real World Outcomes","issn_l":"2198-9788","issn":["2198-9788","2199-1154"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs - Real World Outcomes","raw_type":"journal-article"},{"id":"pmid:42734777","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42734777","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs - real world outcomes","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s40801-026-00579-1","doi":"https://doi.org/10.1007/s40801-026-00579-1","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40801-026-00579-1","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40801-026-00579-1.pdf","source":{"id":"https://openalex.org/S2764379982","display_name":"Drugs - Real World Outcomes","issn_l":"2198-9788","issn":["2198-9788","2199-1154"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs - Real World Outcomes","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320324526","display_name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","ror":"https://ror.org/01g80gk13"},{"id":"https://openalex.org/F4320328224","display_name":"Conservatoire National des Arts et M\u00e9tiers","ror":"https://ror.org/0175hh227"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7212937272.pdf","grobid_xml":"https://content.openalex.org/works/W7212937272.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W4288038265","https://openalex.org/W4293207258","https://openalex.org/W4403458729","https://openalex.org/W4404122679","https://openalex.org/W4409087259","https://openalex.org/W4413780537","https://openalex.org/W7116752520"],"related_works":["https://openalex.org/W7161561109","https://openalex.org/W7161590322","https://openalex.org/W7161547570","https://openalex.org/W4410277011","https://openalex.org/W7163679005","https://openalex.org/W4416635551","https://openalex.org/W4407768531","https://openalex.org/W4387979546","https://openalex.org/W7161557037","https://openalex.org/W3215739139"],"abstract_inverted_index":{"BACKGROUND:":[0],"Pulmonary":[1],"arterial":[2],"hypertension":[3],"(PAH)":[4],"is":[5],"a":[6,22],"rare,":[7],"severe":[8],"and":[9,18,40,81,95,123,139,195,212,247,263],"progressive":[10],"disease":[11],"associated":[12,82],"with":[13,53,73,158,172,239],"poor":[14],"quality":[15],"of":[16,68,118,186,244,265],"life":[17],"high":[19],"mortality.":[20],"Sotatercept,":[21],"first-in-class":[23],"fusion":[24],"protein,":[25],"has":[26],"recently":[27],"been":[28],"shown":[29],"to":[30,64,249,258],"provide":[31,221],"substantial":[32],"clinical":[33,232],"benefit":[34],"as":[35],"add-on":[36],"therapy":[37,148,181,246],"in":[38,44,46,75,84,145,184,230],"PAH":[39,86,147],"was":[41],"made":[42],"available":[43],"France":[45],"2024":[47],"through":[48],"an":[49],"early":[50,120],"access":[51,121],"program,":[52],"eligibility":[54],"criteria":[55],"that":[56],"progressively":[57],"broadened":[58],"over":[59],"time.":[60],"OBJECTIVES:":[61],"We":[62,153],"aimed":[63],"describe":[65],"the":[66,69,90,102,116,119,191,222,250,260],"characteristics":[67,131],"first":[70,223],"patients":[71,111,156,171,214],"treated":[72,157],"sotatercept":[74,114,159,228],"France,":[76],"its":[77],"real-world":[78],"administration":[79],"patterns,":[80],"changes":[83],"background":[85,146,180,245],"therapy.":[87],"METHODS:":[88],"Using":[89],"French":[91,103],"National":[92],"Early":[93],"Access":[94],"Expensive":[96],"Drugs":[97],"Cohort":[98],"(AP-MO),":[99],"derived":[100],"from":[101],"Health":[104],"Data":[105],"System":[106],"(SNDS),":[107],"we":[108],"included":[109,132],"all":[110],"who":[112],"initiated":[113],"since":[115,141],"start":[117],"program":[122],"followed":[124,190],"them":[125],"until":[126],"31":[127],"October":[128],"2025.":[129],"Baseline":[130],"sex,":[133],"age,":[134],"social":[135],"deprivation":[136],"index,":[137],"comorbidities,":[138],"time":[140],"treatment":[142,235],"initiation.":[143],"Changes":[144],"were":[149],"also":[150],"described.":[151],"RESULTS:":[152],"identified":[154],"257":[155],"(median":[160],"age":[161],"53":[162],"years;":[163],"75.5%":[164],"women;":[165],"median":[166],"follow-up":[167,176,207],"8.9":[168],"months).":[169],"Among":[170],"\u2265":[173],"90":[174],"days":[175],"(n":[177],"=":[178],"205),":[179],"remained":[182],"unchanged":[183],"67%":[185],"patients.":[187],"Most":[188],"administrations":[189],"expected":[192],"21-day":[193],"interval,":[194],"94.2%":[196],"received":[197],"at":[198],"least":[199],"one":[200],"dose":[201],"renewal.":[202],"Thirteen":[203],"deaths":[204],"occurred":[205],"during":[206],"(0.55":[208],"per":[209],"100":[210],"person-months),":[211],"two":[213],"underwent":[215],"lung":[216],"transplantation.":[217],"CONCLUSIONS:":[218],"These":[219],"findings":[220],"real-world,":[224],"nationwide":[225],"insights":[226],"into":[227],"use":[229],"routine":[231],"practice,":[233],"showing":[234],"patterns":[236],"broadly":[237],"consistent":[238],"initial":[240],"recommendations,":[241],"including":[242],"maintenance":[243],"adherence":[248],"recommended":[251],"dosing":[252],"interval.":[253],"Further":[254],"studies":[255],"are":[256],"warranted":[257],"assess":[259],"long-term":[261],"effectiveness":[262],"safety":[264],"sotatercept.":[266]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-09-15T00:00:00"}